Meeting
2012 ASCO Annual Meeting
Second malignant neoplasms (SMN) among 18,627 testicular cancer survivors (TCS) after chemotherapy (CHEM) or surgery (SURG).
Authors
Chunkit Fung
James P. Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, NY
Chunkit Fung , Sophie D. Fossa , Michael T Milano , Mandi Yu , Melissa Worman , Lois B. Travis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Cancer Prevention/Epidemiology
Track
Cancer Prevention/Epidemiology
Sub Track
Epidemiology
Citation
J Clin Oncol 30, 2012 (suppl; abstr 1536)
DOI
10.1200/jco.2012.30.15_suppl.1536
Abstract #
1536
Poster Bd #
25
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Second solid (SMN) and hematologic malignant neoplasms (HMN) among 24,900 United States testicular cancer survivors (TCS) after chemotherapy (CHEM), radiotherapy (RT), or surgery only (SURG).
First Author: Mohammad Issam Abu Zaid
Poster
2023 ASCO Genitourinary Cancers Symposium
Impact of chemotherapy on anxiety, depression, and suicidality amongst testicular cancer survivors.
First Author: Tyler J. Nelson
Poster
2021 Genitourinary Cancers Symposium
Paternity, relationship, sexual activity and fertility in testicular cancer (TC) survivors (TCS): Results from a single institution observational prospective study.
First Author: Davide Bimbatti
Poster
2018 ASCO Annual Meeting
Risk of second malignancies in breast cancer patients who received chemotherapy: A SEER analysis.
First Author: Snigdha Nutalapati